Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Simple strategies to develop your digital health vision.

President, Customer Solutions, American Well

Healthcare businesses will experience seismic shifts as consumers take ownership of their data.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Specialty drugs represent an opportunity to better serve patients, but also pose risks.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Actuarial, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.

Researcher, PreScouter

Insights in your inbox

Subscribe

The healthcare industry is finally coming to terms with the fact that disruption is here.

Partner, Health & Life Sciences, Oliver Wyman

Three CEOs discuss why digital treatments are on the cusp of becoming mainstream and share their five-year outlooks.

Partner, Health & Life Sciences, Oliver Wyman
Executive Chairman, President and CEO, Click Therapeutics
Former CEO, SyncThink
CEO, AbleTo

Oliver Wyman has partnered with venture capitalist firms and senior leaders to support those in pursuit of health transformation.

Healthcare systems know M&A, cost transformation, and SDOH can reap big rewards. Bold models will thrive.

A one-size-fits-all SDOH approach isn't the answer. Yet it's the industry norm.

Founder, HICCup & Way to Wellville
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe